Early invasive treatment for elderly heart attack patients
Part of Heart & circulation clinical trials.
This trial tests whether early invasive treatment (like stenting) is safe and effective for patients 60 or older who have a certain type of heart attack called high-risk non-ST-segment elevation acute coronary syndrome. The goal is to see if this approach improves outcomes for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older.
- You have been diagnosed with high-risk non-ST-segment elevation acute coronary syndrome (a type of heart attack).
- You are scheduled to receive a procedure to open blocked arteries, such as angioplasty or stenting.
- Your heart attack is not caused by a blood clot in a previously placed stent or a blocked bypass graft.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how frailty and other health factors affect recovery in people 75 and older who have had a heart attack or unstable chest pain. It may help doctors better understand who is at higher risk and how to improve care for older adults.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This trial studies whether adding a special heart “reset” step (ischemic postconditioning) and using an imaging guide during the emergency procedure can improve outcomes for people having a STEMI heart attack. It’s meant to optimize treatment when a blocked heart artery is being opened.
This trial tests whether placing a stent early in heart arteries with dangerous-looking plaques (sticky buildups) helps prevent heart attacks. You'll be monitored closely with heart imaging to see if early intervention is safer than watching and waiting.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This trial studies whether doing a planned, staged treatment for some artery blockages after a heart attack can improve outcomes. It uses detailed images of the heart arteries and compares results in people who are stable after their initial emergency procedure.
Hear when a new Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.